The need of lung cancer screening - new evidence, new expectations;Potrzeba badań przesiewowych w kierunku wczesnego wykrywania raka płuca - nowe dowody, nowe nadzieje

Pneumonologia i Alergologia Polska

Volumn 79, Issue 6, 2011, Pages 419-427

  Laprus, Izabela ^a   Adamek, Mariusz ^b   Kozielski, Jerzy ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Low dose computed tomography; Lung cancer; Screening

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; EVIDENCE BASED MEDICINE; HUMAN; LUNG; LUNG TUMOR; MASS SCREENING; ORGANIZATION AND MANAGEMENT; POLAND; PRACTICE GUIDELINE; PROGNOSIS; RADIOGRAPHY; RISK FACTOR; SPUTUM; SURVIVAL;

CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; LUNG; LUNG NEOPLASMS; MASS SCREENING; POLAND; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK FACTORS; SPUTUM; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80055103061     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Krzakowski M. (red.). Nowotwory złośliwe płuca i opłucnej. W: Zalecenia poste{ogonek}powania diagnostyczno-terapeutycznego w nowotworach złośliwych. Via Medica, Gdańsk 2009; 1: 68-91.
2. Didkowska J. Epidemiologia i etiopatogeneza raka płuca. W: Jassem J., Krzakowski M. (red.). Nowotwory płuca i opłucnej-praktyczny przewodnik dla lekarzy. Via Medica, Gdańsk 2008; 1-18.
3. Cancer of the Lung and Bronchus-SEER Stat Fact Sheets, http://seer.cancer.govv/ststfacts/html/lungb.html; 1.01.2011.
4. Goldstraw P., Crowley J.J., Chansky K. i wsp. The IASLC Lung Cancer Staging Project: proposal for revision of the stage groupings in the forthcoming (seventh) edition of the TNM classification for lung cancer. J. Thorac. Oncol. 2007; 2: 706-714.
5. Infante M.V., Pedersen J.H. Screening for lung cancer: are we there yet? Curr. Opin. Pulm. Med. 2010; 16: 301-306.
6. Jett J.R. Spiral Computed tomography screening for lung cancer is ready for prime time. Am. J. Respir. Crit. Care Med. 2001; 163: 812-815.
7. Krzakowski M. Wybrane zagadnienia onkologii klinicznej. W: Szczeklik A. (red.). Choroby wewne{ogonek}trzne. MP, Kraków 2006; 2: 1984-1988.
8. Read C., Janes S., George J., Spiro S. Early lung cancer: screening and detection. Prim. Care Resp. J. 2006; 15: 332-336.
9. Olszewski W.T. Badania przesiewowe w kierunku nowotworów. W: Krzakowski M. (red.). Onkologia kliniczna. Borgis Wydawnictwo Medyczne, Warszawa 2006; 1: 53-60.
10. Patz E.F., Goodman P.C., Bepler G. Screening for lung cancer. N. Engl. J. Med. 2000; 342: 1627-1633.
11. Głogowski M. Badania przesiewowe w kierunku raka płuca. W: Jassem J., Krzakowski M. (red.). Nowotwory płuca i opłucnej-praktyczny przewodnik dla lekarzy. Via Medica, Gdańsk 2008; 19-23.
12. National Lung Screening Trial Research Team, The National Lung Screening Trial: Overview and Study Design. Radiology 2011; 258: 243-253.
13. Flehinger B.J., Melamed M.R., Zaman M.B., Heelan R.T., Perchick W.B., Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Ketterin study. Am. Rev. Respir. Dis. 1984; 130: 549-554.
14. Melamed M.R., Flehinger B.J., Zaman M.B., Heelan R.T., Perchick W.A., Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984; 86: 44-51.
15. Melamed M.R. Lung cancer screening results in the National Cancer Institute New York study. Cancer 2000; 89 (supl. 11): 2356-2362.
16. Fontana R.S., Sanderson D.R., Woolner L.B. i wsp. Screening for lung cancer: a critique for the Mayo Lung Project. Cancer 1991; 67: 1155-1164.
17. Sanderson D.R. Lung cancer screening. The Mayo Study. Chest 1986: 89 (supl. 4): 324S.
18. Marcus P.M., Bergstralh E.J., Fagerstrom R.M. i wsp. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J. Natl. Cancer Inst. 2000; 92: 1308-1316.
19. Frost J.K., Ball W.C. Jr., Levin M.L. i wsp. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am. Rev. Respir. Dis. 1984; 130: 549-554.
20. Tockman M.S. Survival and mortality from lung cancer in a screened population: The Johns Hopkins Study. Chest 1986; 89 (supl.): 324S-325S.
21. Kubík A., Polák J. Lung cancer detection: results of a randomized prospective study in Czechoslovakia. Cancer 1986; 57: 2427-2437.
22. Hocking W.G., Hu P., Oken M.M. i wsp. for the PLCO Project Team, Lung Cancer Screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J. Natl. Cancer Inst. 2010; 102: 722-731.
23. Pruszyński B. (red.). Radiologia. Diagnostyka obrazowa, RTG, TK, USG, MR i medycyna nuklearna. Wydawnictwo Lekarskie PZWL, 2003: 51-53.
24. Zhu X., Yu J., Huang Z. Low-dose chest CT: optimizing radiation protection for patients. AJR 2004; 183: 809-816.
25. Kaneko M., Egichi K., Ohmatsu H. i wsp. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 201: 798-802.
26. Sobue T., Moriyama N., Kaneko M. i wsp. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J. Clin. Oncol. 2002; 20: 911-920.
27. Sone S., Li F., Yang Z.G. i wsp. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br. J. Cancer 2001; 84: 25-32.
28. Nawa T., Nakagawa T., Kusano S., Kawasaki Y., Sugawara Y., Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002; 122: 15-20.
29. Henschke C.I., McCauley D.I., Yankelevitz D.F. i wsp. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354: 99-105.
30. Henschke C.I., Naidich D.P., Yankelevitz D.F. i wsp. Early Lung Cancer Action Project: initial findings on repeat screenings. Cancer 2001; 92: 153-159.
31. Swensen S.J., Jett J.R., Hartman T.E. i wsp. CT screening for lung cancer: five year lung prospective experience. Radiology 2005; 235: 259-265.
32. Diederich S., Wormanns D., Semik M. i wsp. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002; 222: 773-781.
33. The International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N. Engl. J. Med. 2006; 355: 1763-1771.
34. International Early Lung Cancer Action Program protocol http:/ /www.IELCAP.org; 8.01.2011.
35. Henschke C.I., Yankelevitz D.F. CT screening for lung cancer: update 2007. The Oncologist 2008; 13: 65-78.
36. International Early Lung Cancer Program Invesitigators. An update of CT screening for lung cancer. Semin. Ultrasound CT MR 2005; 26: 348-356.
37. Grodzki T., Walecka A., Fabian W. i wsp. Program wczesnego wykrywania nowotworów płuc za pomoca{ogonek} tomografii komputerowej-wste{ogonek}pne doświadczenia Szczecina. Pneumonol. Alergol. Pol. 2009; 77: 521-527.
38. Ksia{ogonek}zek J., Dziedzic R., Jelitto-Górska M. i wsp. Pomorski pilotazowy program badań wczesnego wykrywania raka płuca. Doniesienie wste{ogonek}pne. Ann. Acad. Med. Gedan. 2009; 39: 73-82.
39. Mazzone P., Meziane M., Obuchowski N., Ahmad M., Mekhail T. Lung cancer screening: is it time for change in policy? Cleveland Clin. J. Med. 2007; 74: 441-448.
40. Dutch Belgian randomized lung cancer screening trial (NELSON). http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=636; 3.05.2011.
41. Xu D.M., Gietema H., de Koning H. i wsp. Nodule management protocol of the NELSON randomized screening trial. Lung Cancer 2006; 54: 177-184.
42. Pedersen J.H., Ashraf H., Dirksen A. i wsp. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J. Thorac. Oncol. 2009; 4: 608-614.
43. Lopes P.A., Picozzi G., Mascalchi M. i wsp. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009; 64: 34-40.
44. Infante M., Cavuto S., Lutman R. F i wsp. for the DANTE Study Group. A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Three-year results from the DANTE Trial. Am. J. Respir. Crit. Care Med. 2009; 180: 445-453.
45. NLST updates http://www.cancer.gov/newscenter/pressreleases/ 2010/NLSTresultsRelease; 20.07.2011.
46. The National Lung Screening Trial Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011; 365: 395-409.
47. Marek W., Kotschy-Lang N., Muti A. i wsp. Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer? Evaluation of quantitative semi-automated sputum cytometry on radon-and uranium-exposed workers. Eur. Respir. J. 2001; 18: 942-950.
48. Xing S., Khanavkar B., Nakhosteen J.A., Atay Z., Jockel K.H., Merek W. Predictive value of image cytometry for diagnosis of lung cancer in heavy smokers. Eur. Respir. J. 2005; 25: 956-963.
49. Forgacs E., Zochbauer-Muller S., Olah E., Minna J.D. Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol. Oncol. Res. 2001; 7: 6-13.
50. Belinsky S.A., Liechty K.C., Gentry F.D. i wsp. Promoter hypermetylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res. 2006; 66: 3338-3344.
51. Donat P., Ramlau R., Nowak E., Barinow-Wojewódzki A. Bronchoskopia autofluorescencyjna w diagnostyce i leczeniu raka płuca. Kardiochirurgia i Torakochirurgia Polska 2010; 7: 166-169.
52. Venmans B.J., Van Boxem T.J.M., Smit E.F., Postmus P.E., Sutedia T.G. Results of two years experience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia. Diagn. Ther. Endosc. 1999; 5: 77-84.
53. Vermylen P., Pierard P., Roufosse C. i wsp. Detection of bronchial preneoplastic leasions and early lung cancer with fluorescence bronchoscopy: a study about its ambulatory feasibility under local anaesthesis. Lung Cancer 1999; 25: 161-168.
54. Lam S., Kennedy T., Linger M. i wsp. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998; 113: 696-702.
55. Lam S., MacAulay C., LeRiche J.C. i wsp. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 2000; 89 (supl.): 2468-2473.
56. Chirikos T.N., Hazelton T., Tockman M., Clark R. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 2002; 121: 1507-1514.
57. Mahadevia P.J., Fleisher L.A., Frick K.D. i wsp. Lung cancer screening with helical computed tomography in older adult smokers. A decision and cost-effectiveness analysis. JAMA 2003; 289: 313-322.
58. McMahon P.M., Kong C.Y., Johnson B.E. i wsp. Estimating longterm effectiveness of lung cancer screening in the Mayo CT screening study. Radiology 2008; 248: 278-287.